We previously showed that PPT1-deficient mice had a lower tumor burden and a higher survival rate than PPT1-sufficient mice in xenograft tumor models, possibly due to 4-fold expansion of tissue-resident memory CD8+ T cells57. This evidence concerns the gene CD8A and neoplasm.